Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J. Health Biol. Sci. (Online) ; 12(1): 1-7, jan.-dez. 2024. tab
Article in Portuguese | LILACS | ID: biblio-1553701

ABSTRACT

Objetivo: avaliar as notificações de intoxicação exógena por raticida no Brasil entre 2008 e 2022. Métodos: foi realizado um estudo ecológico, do tipo série temporal, avaliando a quantidade anual de notificações nos últimos 15 anos, considerando os casos confirmados pelo Sistema de Informação de Agravos de Notificação (SINAN). A tendência temporal e as razões de incidência antes e durante a pandemia de COVID-19 foram examinadas com nível de significância de 5%. Resultados: entre 2008 e 2022, 48.448 notificações de intoxicação exógena por raticidas foram registradas. A tendência temporal foi estabelecida como estacionária nos últimos 15 anos (p = 0,285), mas tornou-se, significativamente, crescente ao remover os anos relacionados à pandemia de COVID-19 (p = 0,001; VPA = 5,4% [IC95% = 2,1, 8,6). Além disso, ao comparar com período pré-pandemia, a incidência de notificações foi 34% menor (RI = 0,66 [IC95% = 0,59, 0,73]) no primeiro e 28% menor (RI = 0,72 [IC95% = 0,65, 0,79]) no segundo ano da pandemia de COVID-19. Por fim, observou-se que 82,2% das circunstâncias foram tentativas de suicídio, 89,4% foram exposições do tipo aguda-única e a maioria (91,1%) evoluíram para cura sem sequelas. Conclusão: foi possível concluir que as intoxicações exógenas por raticidas persistem como um problema de Saúde Pública no Brasil.


Objectives: to evaluate notifications of exogenous poisoning by rodenticides in Brazil between 2008 and 2022. Methods: an ecological time-series study was carried out, evaluating the annual number of notifications in the last 15 years, considering the cases confirmed by the Notifiable Diseases Information System (SINAN). Temporal tendency and incidence ratios before and during the COVID-19 pandemic were examined at a 5% significance level. Results: between 2008 and 2022, 48,448 notifications of exogenous poisoning by rodenticides were reported. The temporal tendency was established as stationary over the last 15 years (p = 0.285) but became significantly increasing when removing the COVID-19 pandemic years (p = 0.001; VPA = 5.4% [95%CI = 2 .1, 8.6). In addition, when compared to the pre-pandemic period, the incidence of notifications was 34% lower (IRR = 0.66 [CI95% = 0.59, 0.73]) in the first and 28% lower (IRR = 0,72 [CI95% = 0.65, 0.79]) in the second year of the COVID-19 pandemic. At last, it was observed that 82.2% of the circumstances were suicide attempts, 89.4% were acute-single exposures, and most (91.1%) evolved to cure without sequelae. Conclusion: it was possible to conclude that exogenous poisoning by rodenticides persists as a Public Health problem in Brazil.


Subject(s)
Rodenticides , Brazil , Epidemiology
2.
Rev. méd. Chile ; 151(6)jun. 2023.
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1560243

ABSTRACT

La intoxicación humana por rodenticidas anticoagulantes de acción prolongada, conocidos como superwarfarinas, provoca coagulopatía de prolongado manejo. Presentamos el caso de un hombre de 42 años que ingirió una dosis tóxica de rodenticida en un intento suicida, evolucionando con epistaxis, INR de 11,6 y necesidad de hospitalización. Durante 7 días se realizaron controles seriados de pruebas de coagulación, con optimización de diferentes dosis de suplementación de Vitamina K. El caso destaca la potencia y vida media prolongada (aproximadamente 6 semanas) de este tipo de anticoagulantes, hecho que requiere un control clínico regular y una adherencia al tratamiento satisfactoria.


Human intoxication by long-acting anticoagulant rodenticides, known as superwarfarins, causes coagulopathy that is difficult to manage. We present the case of a 42-year-old man who ingested a toxic dose of rodenticide in a suicide attempt, evolving with epistaxis, INR of 11.6, and needing hospitalization. For seven days, serial controls of coagulation tests were carried out, with optimization of different doses of Vitamin K supplementation. The case highlights this type of anticoagulant's potency and prolonged half-life (approximately six weeks), which requires regular clinical control and satisfactory treatment adherence.

3.
Repert. med. cir ; 32(3): 279-283, 2023. tab, graf
Article in Spanish | LILACS, COLNAL | ID: biblio-1526907

ABSTRACT

Introducción: las superwarfarinas son rodenticidas anticoagulantes potentes que provocan una coagulopatía severa y duradera al inhibir los factores de coagulación vitamina K dependientes. La intoxicación es un problema de salud pública creciente debido al uso generalizado de estos compuestos. La presentación clínica puede manifestarse desde casos asintomáticos hasta hemorragias graves y potencialmente mortales. El médico clínico debe tener un alto índice de sospecha de intoxicación en presencia de una coagulopatía sin causa evidente, resistente al tratamiento con vitamina K. Presentación del caso: se presenta un caso de coagulopatía severa secundaria a intoxicación por superwarfarina en un hombre con intento de autoeliminación mediante el uso de difetialona.


Introduction: superwarfarins are potent anticoagulant rodenticides that cause severe long-acting coagulopathy by inhibition of vitamin K-dependent coagulation factors. Superwarfarin poisoning is a growing public health problem due to the widespread use of these compounds. Clinical presentation can range from asymptomatic to severe and life-threatening hemorrhage. Clinicians should be highly aware of superwarfarin poisoning in all patients with unexplained coagulopathy resistant to vitamin K therapy. Case: we present a case of severe coagulopathy due to superwarfarin poisoning in a male patient who attempted suicide with difethialone.


Subject(s)
Humans
4.
Acta toxicol. argent ; 27(2): 60-64, Sept. 2019.
Article in Spanish | LILACS | ID: biblio-1088538

ABSTRACT

Introducción. Los superwarfarinicos (SWF) son una de las herramientas utilizadas por el ser humano para el control de roedores y a la vez son tóxicos para el hombre y pueden conducir a la muerte sin los debidos cuidados en su uso.Casos clinicos. Tres pacientes masculinos, que consultaron por sangrados (gingivorragia, epistaxis, hematuria, hemartrosis y hematomas cutaneos) asociados a alteraciones del coagulograma (Tiempo de protrombina (TP) y tiempo de tromboplastina parcial (KPTT) prolongados). Todos tuvieron exposición a superwarfarinicos. Nuestro servicio no dispone del análisis de SWF en suero. Se administró vitamina K1 en los tres pacientes y plasma fresco congelado (PFC) en uno solo (sangrado mayor: hematuria). El seguimiento se realizó mediante controles seriados de coagulograma y su evolución fue favorable. Discusión. En todos los casos, el diagnóstico de intoxicación por SWF fue clínico, basado en caracteristicas clínicas de pacientes y alteraciones en sus parámetros de coagulación, y debido a imposibilidad de derivación de análisis a otro laboratorio. Se realizo tratamiento especifico (vitamina K1 y PFC) segun recomendación de expertos, ya que no hay hasta la fecha, estudios clinicos que evaluen las diferentes opciones terapéuticas. Conclusión. La intoxicación por SWF aunque no es frecuente, debe sospecharse en casos de paciente con coagulopatia sin otras causas que puedan justificarlo. El manejo del cuadro tóxico es la reposición de vitamina k y de plasma fresco congelado, en casos donde se necesite una rápida corrección de la alteración hemostática, como los sangrados mayores. Es imprescindible la oportuna consulta con médicos hematólogos y/o la consulta con un centro regional de control de intoxicaciones para todas las exposiciones sospechosas por SWF.


Introduction. Superwarfarinics (SWF) are one of the tools used by humans for rodent control. They are toxic to humans and can lead to death without due care in its use. Clinical cases. Three male patients, who consulted due to bleeding (gingivorragia, epistaxis, hematuria, hamartrosis and skin hematomas) associated with coagulogram alterations (prolonged protombine time (PT) and partial thromboplastin time (KPTT)). All them exposure to superwarfarinics. SWF serum analysis was not available in our hospital. Vitamin K1 was administered in all three patients and fresh frozen plasma (PFC) in only one (major bleeding: hematuria). The followup was performed by serial coagulogram controls and the evolution was. Discussion. In all cases, the diagnosis of SWF intoxication was clinical, based on clinical characteristics of patients and alterations in their coagulation parameters, due to the impossibility of deriving the analysis of SWF in serum to another laboratory. Specific treatment was carried out (vitamin k and PFC) according to experts' recommendation, since there are no clinical studies to evaluate the different therapeutic options to date. Conclusion. SWF poisoning, although not frequent, should be suspected in patients with coagulopathy without other causes that may justify it. The management of toxic symptoms is the administration of vitamin K1 and fresh frozen plasma, in cases where a rapid correction of the haemostatic alteration is required, such as major bleedings. It is essential to consult with hematologists and / or consult a regional poison control center for all suspicious exposures by superwarfarins.


Subject(s)
Humans , Male , Adult , Rodenticides/poisoning , Rodenticides/toxicity , Vitamin K/therapeutic use , Argentina , Vitamin K Deficiency Bleeding
5.
Rev Rene (Online) ; 17(1): 3-9, jan.-fev. 2016.
Article in English | LILACS, BDENF | ID: lil-786861

ABSTRACT

Objective: to characterize rodenticide poisoning sold illegally under the name Chumbinho. Methods: this is a descriptive and cross-sectional study by retrospective analysis of epidemiological forms of Toxicological Occurrence of a Toxicological Assistance Center, from 2006 to 2013. Results: 115 forms were analyzed, with an annual average of 14.4 ± 4.8 cases and 35.6% of the records in the fourth biennial. Most poisonings occurred in males (57.3%), aged between 15 and 49 years (78.3%) and suicide attempted (90.4%). It was found clinical severity of cases because 92.1% intoxicated required hospitalization and occurred four deaths (3.5%). Conclusion: the cases of poisoning by Chumbinho increased gradually over the studied years, in males, in an economically active age, and by intentional poisoning. There is a need for greater sanitary inspection in the region, aiming to reduce supply and improvement of guidance to consumers.


Objetivo: caracterizar as intoxicações por raticida comercializado clandestinamente sob a denominação de chumbinho. Métodos: estudo descritivo e transversal, por análise retrospectiva de fichas epidemiológicas de Ocorrência Toxicológica de um Centro de Assistência Toxicológica, dos anos de 2006 a 2013. Resultados: foram analisadas 115 fichas, com média anual de 14,4 ± 4,8 casos e 35,6% dos registros no quarto biênio. A maioria das intoxicações ocorreu no sexo masculino (57,3%), na faixa etária entre 15 e 49 anos (78,3%) e pela circunstância tentativa de suicídio (90,4%). Constatou-se gravidade clínica dos casos, pois 92,1% intoxicados necessitaram de internação hospitalar e aconteceram quatro óbitos (3,5%). Conclusão: os casos de intoxicação por chumbinhoaumentaram gradualmente nos anos estudados, em indivíduos do sexo masculino, em idade economicamente ativa e por intoxicação intencional. Há necessidade de maior fiscalização sanitária na região, visando diminuição da oferta e aprimoramento das orientações aos consumidores.


Subject(s)
Community Health Nursing , Health Surveillance , Poison Control Centers , Poisoning , Rodenticides
6.
Acta toxicol. argent ; 23(1): 44-52, mayo 2015.
Article in Spanish | LILACS | ID: lil-757035

ABSTRACT

Introducción: en la actualidad existe utilización masiva de rodenticidas y su venta no está restringida al público. Las etiologías de intoxicación por estos agentes son variadas pudiendo ser de tipo intencional o accidental. Objetivo: analizar estudios realizados en torno a intoxicaciones con rodenticidas superwarfarínicos en humanos con el propósito de reunir información que oriente a un adecuado tratamiento. Metodología: se realizó una revisión integradora en las bases de datos electrónicas PubMed, TripDataBase, Cochrane, además de Google Scholar y SciELO, libros de divulgación científica, documentos de convenciones, páginas web de instituciones públicas, privadas y artículos vinculados a efectos, cuadro clínico y tratamiento de exposiciones a rodenticidas en seres humanos. Se analizaron los documentos y la información se organizó en tres temáticas: toxicidad de los rodenticidas superwarfarínicos, cuadro clínico y tratamiento médico, y rodenticidas no anticoagulantes disponibles en Chile. Resultados: la dosis tóxica mínima reportada en adultos es de 1 mg de principio activo; en pacientes pediátricos ingestas accidentales rara vez producen síntomas. Los síntomas se observan de forma tardía y su toxicidad es variable. El examen de elección es el International Normalized Ratio (INR) y se realiza en todo paciente con factores de riesgo presentes. El antídoto no se administra de forma profiláctica y la dosis se ajusta individualmente. Conclusión: en niños las ingestas accidentales no son riesgosas por lo que pueden ser observados en el hogar. Pacientes con ingestas masivas requieren controles de INR por meses por lo que es importante que posterior al alta médica exista una óptima coordinación con nivel primario de atención.


Introduction: Currently there is a widespread use of rodenticides, unrestricted to the public. The exposure to these agents may varied being intentional or accidental. Objective: To analyze studies about superwarfarin poisoning in humans, with the purpose of gathering information to guide proper treatment. Methodology: It was conducted an integrative review in the electronic databases PubMed, TripDataBase, Cochrane, Google Scholar and SciELO, science books (reference textbooks), convention documents, websites from public and private institutions and articles about the effects, clinical manifestations and treatment of human exposures to rodenticides. Documents were analyzed and the information organized into three themes: superwarfarin toxicity, clinical features and medical treatment, and non-anticoagulant rodenticides available in Chile. Results: In adults, the minimum dose reported to cause toxicity is 1 mg of active ingredient. In pediatric patients, accidental intakes rarely produce symptoms. The symptoms of poisoning are usually delayed and its toxicity is variable. The test of choice is International Normalized Ratio (INR) and it is performed in all patients with risk factors. The antidote must not be administered prophylactically and the dose is adjusted individually. Conclusions: Accidental intakes in children are not risky and they can be observed at home. Patients with massive intakes require INR monitoring for months so, it is important that an optimal coordination with primary care facilities still exists after medical discharge.


Subject(s)
Humans , Rodenticides/toxicity , Vitamin K 1/therapeutic use , Rodenticides/antagonists & inhibitors , Rodenticides/poisoning
7.
Rev. peru. med. exp. salud publica ; 27(4): 578-585, dic. 2010. ilus, tab
Article in Spanish | LILACS, LIPECS | ID: lil-573938

ABSTRACT

Se realizó una búsqueda sistemática para identificar publicaciones sobre la seguridad ante la exposición de raticidas que contienen Salmonella para humanos y animales. Se consideraron publicaciones a texto completo que incluían descripción de su metodología y la presentación adecuada de sus resultados. De 545 publicaciones recuperadas, 47 se revisaron a texto completo de las que se seleccionaron 12. En seis se reportan casos de salmonelosis en humanos, incluso casos fatales, asociados a la exposición a versiones anteriores de estos raticidas. El único ensayo clínico encontrado reporta una mayor frecuencia de diarrea y fiebre en el grupo que ingirió Salmonella contenida en Biorat® (presentación comercial actual); sin embargo, la diferencia no fue estadísticamente significativa, pero el ensayo presentó problemas metodológicos. Las cepas de Salmonella enteritidis contenidas en una versión anterior (Ratin®) y en la versión actual corresponden a la misma variedad (Danysz) y fagotipo (6a), y están cercanamente relacionadas según la técnica de electroforesis en gel de campo pulsado (PFGE). No se reporta efectos patógenos de esta Salmonella para las diferentes especies de animales ensayadas; sin embargo, se encontraron limitaciones en la metodología empleada. Se concluye que la Salmonella enteritidis contenida en versiones anteriores de raticidas produjo enfermedad en humanos por lo que fue prohibida su comercialización y que existiría un riesgo potencial de la versión actual por contener una bacteria muy similar y por no tener evidencia suficiente que garantice su seguridad. Son necesarios estudios bien diseñados por instituciones sin conflicto de interés, antes de su aplicación en salud pública o agricultura.


We conducted a systematic search of the literature to identify publications on the safety of exposure to Salmonella-based rodenticides by humans and animals. We included full-text publications that described the methods and presented their results satisfactorily. Of 545 publications retrieved, 47 were reviewed in full text and from those 12 were selected. Six reports featured cases of salmonellosis in humans, with fatal cases, associated with exposure to previous versions of this type of rodenticide. A clinical trial reported an increased frequency of diarrhea and fever in the group that ingested Biorat ® (the current commercial form) containing Salmonella, however the difference from the control group was not significant, but the trial had methodological problems. Strains of Salmonella enteritidis from an earlier version of the rat poison (Ratin®) and those in the current version correspond to the same variety (Danyzs) and phage type (6a), and were found to be closely related using the technique of pulsed field gel electrophoresis (PFGE). No pathogenic effects of this Salmonella were reported in different animal species tested; however, we found limitations in the methodology. We conclude that the Salmonella enteritidis contained in earlier rat poison formulations produced illness in humans so that its commercialization was prohibited, and that there would be a potential risk with the present formulation because it contains a very similar bacteria, and because there is not sufficient evidence to guarantee its safety. Well-designed studies still need to be done by institutions that do not have a conflict of interest before it can be applied in the areas of public health and agriculture.


Subject(s)
Humans , Pest Control, Biological , Rodenticides/adverse effects , Salmonella , Public Health
8.
Rev. cuba. med. trop ; 47(2): 83-87, jul.-dic. 1995.
Article in Spanish | LILACS | ID: lil-629246

ABSTRACT

Se calculó la actividad en las madrigueras en 4 objetivos diferentes, ésta fue del 80 al 98 % durante el pretratamiento. Por primera vez en nuestro país se obtuvieron los valores promedios de días/muertes de los roedores sinantrópicos en condiciones naturales, se alcanzaron valores entre 16,50 y 19,06 después de la aplicación del biorrodenticida. En el análisis estadístico se encontró que hay diferencia significativa en el conjunto de objetivos en relación con los promedios de días/muertes (H= 8,60*; p < 0,05). Además, no se detectaron diferencias significativas entre los tantos por cientos de actividad residual en las madrigue ras (G= 8,27; p 0,05). Los resultados obtenidos demuestran que el biorrodenticida Salmocumarín es mucho más efectivo donde existen grandes poblaciones de estas especies de roedores cosmopolitas.

SELECTION OF CITATIONS
SEARCH DETAIL